Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure ...

A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.

Triple click chemistry has revolutionized chemical synthesis with its simplicity and efficiency, allowing for the quick and selective assembly of complex molecules. Now, in a recent study, researchers ...

Middle molecules with a molecular weight of more than 1,000 are difficult to synthesize due to multiple steps and time-consuming nature, demanding the development of a new approach that can overcome ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

There is growing enthusiasm about China’s potential to speed up drug development with AI. And companies outside the country ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The company states the acquisition will further MERIT’s service offerings, allowing for a seamless transition from ...